(Q48762574)

15 February 2018

title

Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. (English)

1 reference

15 February 2018

1 reference

Motomura M

1

1 reference

15 February 2018

Lang B

2

1 reference

15 February 2018

Johnston I

3

1 reference

15 February 2018

Palace J

4

1 reference

15 February 2018

Vincent A

5

1 reference

15 February 2018

Newsom-Davis J

6

1 reference

15 February 2018

publication date

1 March 1997

1 reference

15 February 2018

Journal of the Neurological Sciences

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 February 2018

volume

147

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

35-42

1 reference

15 February 2018

Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Inhibition of acetylcholine release from mouse motor nerve by a P-type calcium channel blocker, omega-agatoxin IVA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Autoantibody specificities in Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Calcium Spike Electrogenesis and Other Electrical Activity in Continuously Cultured Small Cell Carcinoma of the Lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

An improved diagnostic assay for Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Multiple types of neuronal calcium channels and their selective modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905303-8

10.1016/S0022-510X(96)05303-8

7 January 2021

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

9094058

1 reference

15 February 2018